Ozempic and Wegovy maker ‘just scratching the surface’ in meeting demand for weight loss drugs, CEO says
By Meg Tirrell, CNN (CNN) — It could take years before Novo Nordisk has fulfilled demand for its highly popular weight loss drug, the company’s chief executive told CNN, noting that there are more than 100 million Americans with obesity and that “many of those would like to be on treatment.” The Danish drugmaker has
Continue Reading